Paper17308
Paradoxical response to dopamine agonists in tardive dyskinesia.
Carroll BJ and 2 others. Am J Psychiatry, 1977. Cited by 107 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Paradoxical response to dopamine agonists in tardive dyskinesia. Papers, record 17308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17308
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic alpha-Agonists | Major topic |
| Apomorphine | Major topic |
| Dyskinesia, Drug-Induced | Major topic |
| Levodopa | Major topic |
| Adult | |
| Amantadine | |
| Benztropine | |
| Clozapine | |
| Deanol | |
| Dextroamphetamine | |
| Dose-Response Relationship, Drug | |
| Drug Antagonism | |
| Drug Tolerance | |
| Female | |
| Haloperidol | |
| Humans | |
| Physostigmine | |
| Receptors, Dopamine | |
| Reserpine | |
| Stimulation, Chemical | |
| Thioridazine |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 107 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,180,741 | A systematic review on the use of clozapine in treatment of tardive dyskinesia and tardive dystonia in patients with psychiatric disorders. | Psychopharmacology (Berl) | 2022 | https://conductscience.org/library/papers/36180741 | PubMed |
| 18,506,387 | Induction of tolerance of dopaminergic responses in man. | J Neural Transm (Vienna) | 2008 | https://conductscience.org/library/papers/18506387 | PubMed |
| 11,772,117 | Effects of newer antipsychotics on extrapyramidal function. | CNS Drugs | 2002 | https://conductscience.org/library/papers/11772117 | PubMed |
| 11,394,190 | Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma? | J Psychiatry Neurosci | 2001 | https://conductscience.org/library/papers/11394190 | PubMed |
| 6,817,377 | Small doses of apomorphine induce catalepsy and antagonize methamphetamine stereotypy in rats. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6817377 | PubMed |
| 6,663,299 | Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias. | J Neural Transm | 1983 | https://conductscience.org/library/papers/6663299 | PubMed |
| 6,136,552 | Sustained levodopa therapy in tardive dyskinesia. | J Neurol Neurosurg Psychiatry | 1983 | https://conductscience.org/library/papers/6136552 | PubMed |
| 6,126,902 | Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6126902 | PubMed |
| 3,156,964 | EMD 23,448: effects of a putative dopamine autoreceptor agonist in chorea. | J Neural Transm | 1985 | https://conductscience.org/library/papers/3156964 | PubMed |
| 2,813,668 | Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia--a retrospective study of 387 patients. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2813668 | PubMed |
| 2,813,663 | Tolerability of long term clozapine treatment. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2813663 | PubMed |
| 2,682,732 | Clozapine: neuroleptic-induced EPS and tardive dyskinesia. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2682732 | PubMed |
| 2,567,032 | Yawning and suppression of exploration in amphetamine-treated rats, incompatibility with the autoreceptor hypothesis. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2567032 | PubMed |
| 2,528,780 | On the selectivity and specificity of the antagonism of apomorphine-induced suppression of exploration by sulpiride. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2528780 | PubMed |
| 1,738,786 | Do autoreceptors mediate dopamine agonist--induced yawning and suppression of exploration? A critical review. | Psychopharmacology (Berl) | 1992 | https://conductscience.org/library/papers/1738786 | PubMed |
| 381,595 | Six month evaluation of thiopropazate hydrochloride in tardive dyskinesia. | J Neurol Neurosurg Psychiatry | 1979 | https://conductscience.org/library/papers/381595 | PubMed |
| 280,396 | What's new in the psychopharmacology of schizophrenia. | Bull N Y Acad Med | 1978 | https://conductscience.org/library/papers/280396 | PubMed |
| 117,492 | Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/117492 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17308
GET https://conductscience.org/api/papers/v1/17308/authors